Germany Aminoglycosides Market Size & Outlook, 2025-2030
Related Markets
Germany aminoglycosides market highlights
- The Germany aminoglycosides market generated a revenue of USD 109.0 million in 2024 and is expected to reach USD 134.1 million by 2030.
- The Germany market is expected to grow at a CAGR of 3.6% from 2025 to 2030.
- In terms of segment, gentamicin was the largest revenue generating product in 2024.
- Tobramycin is the most lucrative product segment registering the fastest growth during the forecast period.
Aminoglycosides market data book summary
| Market revenue in 2024 | USD 109.0 million |
| Market revenue in 2030 | USD 134.1 million |
| Growth rate | 3.6% (CAGR from 2025 to 2030) |
| Largest segment | Gentamicin |
| Fastest growing segment | Tobramycin |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gentamicin, Tobramycin, Amikacin, Kanamycin, Paromomycin, Neomycin, Streptomycin |
Other key industry trends
- In terms of revenue, Germany accounted for 5.7% of the global aminoglycosides market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany aminoglycosides market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 117.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aminoglycosides Market Scope
Aminoglycosides Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Viatris Inc. | View profile | - | - | - |
| Merck & Co., Inc. | View profile | - | - | - |
| AbbVie Inc. | View profile | - | - | - |
| Pfizer Inc. | View profile | - | - | - |
| Sun Pharmaceutical Industries Ltd. | View profile | - | - | - |
| Fresenius Kabi | View profile | 10001+ | Bad Homburg, Hessen, Germany, Europe | https://www.fresenius-kabi.se |
| Aurobindo Pharma | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://aurobindo.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Germany aminoglycosides market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aminoglycosides market will help companies and investors design strategic landscapes.
Gentamicin was the largest segment with a revenue share of 35.14% in 2024. Horizon Databook has segmented the Germany aminoglycosides market based on gentamicin, tobramycin, amikacin, kanamycin, paromomycin, neomycin, streptomycin covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Germany aminoglycosides market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany aminoglycosides market databook
-
Our clientele includes a mix of aminoglycosides market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany aminoglycosides market , including forecasts for subscribers. This country databook contains high-level insights into Germany aminoglycosides market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Germany aminoglycosides market size, by product, 2018-2030 (US$M)
Germany Aminoglycosides Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
